Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein Y, R
1
, R
2
, R
4
and n have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
公式(I)的HCV复制
抑制剂,包括立体
化学异构体形式、盐、
水合物、溶剂化物,其中Y、R1、R2、R4和n的含义如权利要求所定义。本发明还涉及制备上述化合物的方法、含有它们的药物组合物和它们在HCV治疗中的应用。